Toxicity From Sotorasib After Immune Checkpoint Inhibitors: A Note of Caution and Reflections of Future Advancements in the Field
J Thorac Oncol
.
2023 Oct;18(10):1265-1267.
doi: 10.1016/j.jtho.2023.07.013.
Authors
Aakash Desai
1
,
Anastasios Dimou
2
Affiliations
1
Division of Medical Oncology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama.
2
Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: dimou.anastasios@mayo.edu.
PMID:
37758343
DOI:
10.1016/j.jtho.2023.07.013
No abstract available
Publication types
Editorial